Company
Headquarters: Shenzhen, China
Employees: 476
CN¥3.33 Billion
CNY as of Jan. 1, 2025
US$456.9 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers detection equipment for use in the fields of food, agricultural, dairy, meat, aquatic, honey, drug, and public safety, as well as clinical diagnosis. The company was founded in 2007 and is based in Shenzhen, China.
Shenzhen Bioeasy Biotechnology Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300942 wb_incandescent